Quantcast
Last updated on April 16, 2014 at 6:45 EDT

Latest Vagus nerve stimulation Stories

2013-12-19 23:04:23

Transparency Market Research Report has published "Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018" to its database. Browse full report with TOC: http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html Albany, New York, USA (PRWEB) December 19, 2013 According to a new market report published by Transparency Market Research "Neuromodulation Devices Market - Global Industry Analysis,...

2013-12-08 12:21:25

Investigators present results at the American Epilepsy Society (AES) meeting in Washington, DC HOUSTON, Dec. 8, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) announced today that results from the E-36 clinical study of the AspireSR generator were presented at the annual AES Meeting, taking place December 6-10 at the Walter E. Washington Convention Center in Washington, D.C. Paul Boon, M.D., Ph.D., Senior Full Professor of Neurology and Director of Ghent Institute for...

2013-12-03 23:20:24

Transparency Market Research published a new "Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018" market research report to its report store. Browse the report with request TOC, visit http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html. Albany, New York, USA (PRWEB) December 03, 2013 According to a new market report published by Transparency Market Research "Neuromodulation Devices...

2013-11-25 08:28:01

HOUSTON, Nov. 25, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 25(th) Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2013, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 2:30 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link...

2013-11-23 23:00:06

Malichi Bell from Jacksonville, FL, had surgery at Wolfson Children's Hospital to disconnect the left side of his brain from the right to stop seizures that were leading to serious injuries. (PRWEB) November 24, 2013 Christina Bell and her husband Troy didn’t suspect anything was wrong with their newborn son when he was born in 2005. Not until he was 9 months old when, while in the care of Troy’s grandmother, Malichi had his first seizure and began convulsing. “I had just left...

2013-11-21 11:33:22

UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants in a small clinical trial. Drs. Sven Vanneste and Michael Kilgard of the School of Behavioral and Brain Sciences used a new method pairing vagus nerve stimulation (VNS) with auditory tones to alleviate the symptoms of chronic tinnitus. Their results were published on Nov. 20 in the...

2013-11-20 08:29:07

DETROIT, Nov. 20, 2013 /PRNewswire/ -- Because of its participation in a pivotal trial, Henry Ford Hospital will be the first in Michigan to offer electric stimulation of the brain using a newly FDA-approved device for hard-to-treat epilepsy cases. Called the NeuroPace Responsive Neurostimulation (RNS) System, the device has been shown to provide significant relief to the thousands of epilepsy patients with intractable seizures for whom drugs and other treatments have not worked....

2013-11-05 16:26:01

DUBLIN, Ireland, November 5, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/v39d69/nerve_repair_and) has announced the addition of the "Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018" [http://www.researchandmarkets.com/research/v39d69/nerve_repair_and ] report to their offering. <start_newscom> (Logo:...

2013-10-30 23:03:55

Multidisciplinary Team of Doctors at The Mount Sinai Hospital Testing Innovative Heart Failure Therapy in Global Clinical Trial New York, NY (PRWEB) October 30, 2013 A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath, and heart arrhythmias,...

2013-10-29 08:29:56

ALBANY, New York, October 29, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Neurology Devices Market (CSF Shunts, CSF Drainage, Clot Retriever, Snare, Embolic Coil, Flow Diversion, Neurosurgery & Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global neurology devices market was valued at USD 5.0 billion in 2012 and is expected to grow at a CAGR of 15.4%...